October 29, 2012
Janssen Pharmaceutical introduced an output-oriented education and training system for new MRs this fiscal year with the aim of producing “consulting MRs.” The company, which markets products in a number of fields including the Alzheimer’s disease treatment Reminyl (galantamine), the...read more